Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Stevens, A. Barnard, W. Liu, I. Kilty, M. Yeadon (Sandwich, United Kingdom). Response of novel pan-JAK inhibitor in COPD peripheral blood mononuclear cells. Eur Respir J 2010; 36: Suppl. 54, 2127

Member's Comments

No comment yet.

Related content which might interest you: Treatment of COPD exacerbations is able to influence the mononuclear cells level of the peripheral blood Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 In vitro responses of peripheral blood mononuclear cells in severe asthma patient treated with Mepolizumab Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Expression of phosphorylated IκBα (p-IκBα) in peripheral blood mononuclear cells (PBMC) from glucocorticoid (GC)-dependent asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 354s Year: 2001 Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006 Formoterol, but not salmeterol, restores corticosteroid sensitivity in peripheral blood mononuclear cells from COPD via PI3K inhibition Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Posaconazole in vitro action on peripheral blood mononuclear cells from sarcoidosis patients Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Increased cytokine production by peripheral blood mononuclear cells (PBMC) and alveolar macrophages (AM) in active sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 177s Year: 2003 Downregulation of mir-146a in peripheral blood mononuclear cells as a potential marker of NSCLC Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Cytokine production induced by soluble and particulate stimuli in human peripheral blood mononuclear cells: modulation by pharmacological agents Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004 The in vitro effect of vitamin D on peripheral blood mononuclear cell cytokine expression in COPD Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 B cell activating factor and peripheral tolerance in COPD Source: Annual Congress 2010 - Pathology and immunology of COPD Year: 2010 Glucocorticoid sensitivity of peripheral mononuclear cells in children with asthma Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Expression of hyperoxidized peroxiredoxins is enhanced in peripheral blood mononuclear cells of bronchial asthma patients Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Anti-inflammatory activity of macrolides in peripheral blood mononuclear cells and the identification of potential biomarkers of azithromycin administration Source: Annual Congress 2011 - Phagocytes and dendritic cells Year: 2011 Apoptosis of peripheral blood lymphocytes in different periods of asthma Source: Annual Congress 2011 - T-cell subsets Year: 2011 Studies on blood lymphocytes apoptosis in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Spontaneous release of interferon by peripheral blood mononuclear cells (PBMC) in patients with cystic fibrosis (CF) Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Characterisation of dendritic cells generated from peripheral blood monocytes of NSCLC patients Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Pentoxifylline (PTX) inhibits angiogenesis induced by human peripheral blood mononuclear cells (PBMC) and decreases the release of TNFα not influencing IFNγ release Source: Eur Respir J 2001; 18: Suppl. 33, 353s Year: 2001